Evidence map›Paper›PMID 31230933›Full record

Trial reportInternational journal of cardiology2019

Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial.

Yaron Arbel, Valentin Fuster, Usman Baber, Taye H Hamza, F S Siami, Michael E Farkouh

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Coronary Artery Bypass Grafting: A Review of Short- and Long-Term Outcomes.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Review
  6. Article
  7. Article
  8. Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Yaron ArbelDepartment of Cardiology, Tel Aviv Medical Center, Affiliated with the University of Tel Aviv, Tel Aviv, Israel. Electronic address: yarona@tlvmc.gov.il.
Valentin FusterIcahn School of Medicine at Mount Sinai, New York, USA; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Usman BaberIcahn School of Medicine at Mount Sinai, New York, USA; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Taye H HamzaNew England Research Institute (NERI), USA.
F S SiamiNew England Research Institute (NERI), USA.
Michael E FarkouhPeter Munk Cardiac Centre, and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Canada.
Icahn School of Medicine at Mount Sinai · USNew England Research (United States) · USTel Aviv University · ILUniversity of Toronto · CA

Funding

Coronary Revascularization in Diabetic PatientsU01HL071988 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FUSTER, VALENTIN · 2004 to 2011
$24.2M
Novel Imaging to Predict Cardiovascular Events in DiabetesR01HL092989 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FARKOUH, MICHAEL E, FAYAD, ZAHI A. · 2009 to 2010
$1.6M
NHLBI NIH HHS R01 HL092989NHLBI NIH HHS U01 HL071988
6 · The paper itself

Abstract

backgroundThe incidence and prognostic significance of acute kidney injury (AKI) in patients with diabetes mellitus and multivessel coronary artery disease undergoing coronary revascularization is not well known. The current analysis included patients randomized to PCI vs. CABG as part of the FREEDOM trial. We sought to examine the impact of AKI and its predictors in diabetic patients with multivessel coronary artery disease undergoing PCI vs. CABG.

methodsWe conducted a pre-specified subgroup analysis of the FREEDOM trial to examine the incidence, correlates and impact of AKI according to revascularization strategy. AKI predictors were identified using multivariable logistic regression and associations between AKI and outcomes were examined using Cox regression. The primary endpoint was the composite occurrence of all-cause death, stroke or myocardial infarction at 5 years of follow-up.

resultsKI occurred more frequently in patients following CABG (15.6%) compared with PCI (9.1%) (p < 0.001). AKI was associated with a higher risk for major cardiovascular events (MACE) at 5 years (34.6% vs. 20.5%, p < 0.001), an effect that remained large and significant irrespective of CABG (HR = 2.18 95% CI 1.44-3.31, p ≤0.001) or PCI (HR = 2.08 95% CI 1.35-3.21, p < 0.0001). There was a non-significant interaction (p-value = 0.89) between the revascularization method and AKI, supporting that AKI is a significant risk factor in both revascularization methods.

conclusionsAlthough risk for AKI was higher in patients undergoing CABG, the impact of AKI on MACE was substantial irrespective of revascularization strategy. Preventive strategies to identify patients at risk for AKI are warranted to mitigate the long-term effects of this complication.

Indexed as

Acute Kidney InjuryCoronary Artery BypassCoronary Artery DiseasePercutaneous Coronary InterventionComorbidityCorrelation of DataDiabetes MellitusFemaleHumansIncidenceMaleMiddle AgedRisk AdjustmentRisk FactorsSeverity of Illness IndexAKIComplicationsDiabetes mellitusKidney injuryRevascularization

Identifiers

PMID31230933
PMCPMC6710128
OpenAlexW2950844378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.